TLSI

TriSalus Life Sciences, Inc.

Insider trading activity for TriSalus Life Sciences, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

+$1.8M

net buying

Bought(6 · 5 insiders): $1.8M
Sold(1 · 1 insiders): $1.4K

Past 12 months

+$3.5M

net buying

Bought(12 · 6 insiders): $3.6M
Sold(15 · 5 insiders): $135.8K

Transaction history

The 88 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jul 1	Patience David	Chief Financial Officer	FTAX	14,650	$4.46	$65.3K	-5.3%	Open the original filing on SEC.gov
Jun 30	Szela Mary T	CEO and President	AGRANT	3,990	$3.87	$15.4K	+0.4%	Open the original filing on SEC.gov
Jun 30	Marshak Richard	Chief Commercial Officer	AGRANT	561	$3.87	$2.2K	+0.4%	Open the original filing on SEC.gov
Jun 29	Marshall Richard Henry	Chief Medical Officer	AGRANT◆	120,000	—	—	—	Open the original filing on SEC.gov
Jun 29	Marshall Richard Henry	Chief Medical Officer	AGRANT	60,000	—	—	+200.0%	Open the original filing on SEC.gov
May 15	Wahlstrom Mats	Director	PBUY★	60,000	$2.53	$151.8K	+68.5%	Open the original filing on SEC.gov
May 15	Szela Mary T	CEO and President	PBUY↓	39,682	$2.59	$102.8K	+3.9%	Open the original filing on SEC.gov
May 15	Stansky Michael P	Director	PBUY	200,000	$2.50	$500K	+100.2%	Open the original filing on SEC.gov
May 15	Stansky Michael P	Director	PBUY↓	410,000	$2.50	$1M	+49.4%	Open the original filing on SEC.gov
May 15	Patience David	Chief Financial Officer	PBUY↓	7,100	$2.43	$17.3K	+2.6%	Open the original filing on SEC.gov
May 15	Gordon Gary B.	Director	PBUY↓	10,000	$2.46	$24.6K	+16.0%	Open the original filing on SEC.gov
May 15	Marshak Richard	Chief Commercial Officer	SSELL	543	$2.67	$1.4K	-0.4%	Open the original filing on SEC.gov
May 14	Wahlstrom Mats	Director	AGRANT◆	75,204	—	—	—	Open the original filing on SEC.gov
May 14	Wahlstrom Mats	Director	AGRANT	34,226	—	—	+64.2%	Open the original filing on SEC.gov
May 14	Wahlstrom Mats	Director	AGRANT	37,602	—	—	+239.1%	Open the original filing on SEC.gov
May 14	Valle William	Director	AGRANT◆	56,403	—	—	—	Open the original filing on SEC.gov
May 14	Valle William	Director	AGRANT	24,553	—	—	+41.8%	Open the original filing on SEC.gov
May 14	Valle William	Director	AGRANT	28,201	—	—	+92.5%	Open the original filing on SEC.gov
May 14	Stansky Michael P	Director	AGRANT◆	47,003	—	—	—	Open the original filing on SEC.gov
May 14	Stansky Michael P	Director	AGRANT	20,089	—	—	+2.5%	Open the original filing on SEC.gov
May 14	Stansky Michael P	Director	AGRANT	23,501	—	—	+3.0%	Open the original filing on SEC.gov
May 14	Matlin David J	Director	AGRANT◆	56,403	—	—	—	Open the original filing on SEC.gov
May 14	Matlin David J	Director	AGRANT	23,065	—	—	+1.8%	Open the original filing on SEC.gov
May 14	Matlin David J	Director	AGRANT	28,201	—	—	+2.2%	Open the original filing on SEC.gov
May 14	Hicks Kerry R	Director	AGRANT◆	56,403	—	—	—	Open the original filing on SEC.gov
May 14	Hicks Kerry R	Director	AGRANT	28,201	—	—	+5.5%	Open the original filing on SEC.gov
May 14	Gordon Gary B.	Director	AGRANT◆	56,403	—	—	—	Open the original filing on SEC.gov
May 14	Gordon Gary B.	Director	AGRANT	24,553	—	—	+64.7%	Open the original filing on SEC.gov
May 14	Gordon Gary B.	Director	AGRANT	28,201	—	—	+289.1%	Open the original filing on SEC.gov
Mar 17	Szela Mary T	CEO and President	SSELL	15,944	$3.85	$61.4K	-2.1%	Open the original filing on SEC.gov
Mar 16	Stevens Jennifer	Chief Regulatory Officer	SSELL	774	$4.12	$3.2K	-0.6%	Open the original filing on SEC.gov
Mar 16	Marshak Richard	Chief Commercial Officer	SSELL	419	$4.12	$1.7K	-0.4%	Open the original filing on SEC.gov
Mar 16	Devlin Jodi	Chief of Clinical…	SSELL	273	$4.12	$1.1K	-0.3%	Open the original filing on SEC.gov
Mar 16	Cox Bryan F.	Chief of Research	SSELL	579	$4.12	$2.4K	-0.4%	Open the original filing on SEC.gov
Mar 12	Stevens Jennifer	Chief Regulatory Officer	SSELL	1,552	$4.09	$6.3K	-1.2%	Open the original filing on SEC.gov
Mar 12	Marshak Richard	Chief Commercial Officer	SSELL	1,589	$4.09	$6.5K	-1.4%	Open the original filing on SEC.gov
Mar 12	Devlin Jodi	Chief of Clinical…	SSELL	1,772	$4.09	$7.2K	-1.8%	Open the original filing on SEC.gov
Mar 12	Cox Bryan F.	Chief of Research	SSELL	1,467	$4.09	$6K	-0.9%	Open the original filing on SEC.gov
Mar 11	Szela Mary T	CEO and President	SSELL	4,358	$4.13	$18K	-0.6%	Open the original filing on SEC.gov
Mar 11	Stevens Jennifer	Chief Regulatory Officer	SSELL	1,204	$4.13	$5K	-0.9%	Open the original filing on SEC.gov
Mar 11	Marshak Richard	Chief Commercial Officer	SSELL	1,449	$4.13	$6K	-1.3%	Open the original filing on SEC.gov
Mar 11	Devlin Jodi	Chief of Clinical…	SSELL	1,162	$4.13	$4.8K	-1.2%	Open the original filing on SEC.gov
Mar 11	Cox Bryan F.	Chief of Research	SSELL	1,138	$4.13	$4.7K	-0.7%	Open the original filing on SEC.gov
Feb 23	Valle William	Director	PBUY★	30,487	$4.10	$125K	—	Open the original filing on SEC.gov
Feb 23	Szela Mary T	CEO and President	PBUY★	30,487	$4.10	$125K	+4.1%	Open the original filing on SEC.gov
Feb 23	Stansky Michael P	Director	PBUY	117,198	$4.10	$480.5K	+142.1%	Open the original filing on SEC.gov
Feb 23	Stansky Michael P	Director	PBUY★	243,900	$4.10	$1M	+44.9%	Open the original filing on SEC.gov
Feb 23	Patience David	Chief Financial Officer	PBUY★	3,657	$4.10	$15K	+1.4%	Open the original filing on SEC.gov
Feb 23	Gordon Gary B.	Director	PBUY★	9,756	$4.10	$40K	—	Open the original filing on SEC.gov
Feb 4	Stansky Michael P	Director	AGRANT◆	92,537	—	—	—	Open the original filing on SEC.gov
Nov 24, 2025	Szela Mary T	CEO and President	AGRANT◆	250,000	—	—	—	Open the original filing on SEC.gov
Nov 24, 2025	Szela Mary T	CEO and President	AGRANT	300,000	—	—	+67.8%	Open the original filing on SEC.gov
Nov 24, 2025	Szela Mary T	CEO and President	AGRANT	125,000	—	—	+39.3%	Open the original filing on SEC.gov
Nov 24, 2025	Stevens Jennifer	Chief Regulatory Officer	AGRANT◆	100,000	—	—	—	Open the original filing on SEC.gov
Nov 24, 2025	Stevens Jennifer	Chief Regulatory Officer	AGRANT	50,000	—	—	+64.4%	Open the original filing on SEC.gov
Nov 24, 2025	Patience David	Chief Financial Officer	AGRANT◆	130,000	—	—	—	Open the original filing on SEC.gov
Nov 24, 2025	Patience David	Chief Financial Officer	AGRANT	65,000	—	—	+32.5%	Open the original filing on SEC.gov
Nov 24, 2025	Marshak Richard	Chief Commercial Officer	AGRANT◆	120,000	—	—	—	Open the original filing on SEC.gov
Nov 24, 2025	Marshak Richard	Chief Commercial Officer	AGRANT	60,000	—	—	+111.4%	Open the original filing on SEC.gov
Nov 24, 2025	Devlin Jodi	Chief of Clinical…	AGRANT◆	100,000	—	—	—	Open the original filing on SEC.gov
Nov 24, 2025	Devlin Jodi	Chief of Clinical…	AGRANT	50,000	—	—	+98.9%	Open the original filing on SEC.gov
Nov 24, 2025	Cox Bryan F.	Chief of Research	AGRANT◆	80,000	—	—	—	Open the original filing on SEC.gov
Nov 24, 2025	Cox Bryan F.	Chief of Research	AGRANT	40,000	—	—	+31.6%	Open the original filing on SEC.gov
Aug 28, 2025	Patience David	Chief Financial Officer	AGRANT◆	248,899	—	—	—	Open the original filing on SEC.gov
Aug 14, 2025	Patience David	Chief Financial Officer	AGRANT◆	290,000	—	—	—	Open the original filing on SEC.gov
Aug 14, 2025	Patience David	Chief Financial Officer	AGRANT	200,000	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Matlin David J	Director	CCONV◆	100,000	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Matlin David J	Director	CCONV	330,000	—	—	+35.0%	Open the original filing on SEC.gov
Jul 31, 2025	Frankenius Equity AB	10% Owner	CCONV◆	230,000	—	—	—	Open the original filing on SEC.gov
Jul 31, 2025	Frankenius Equity AB	10% Owner	CCONV	759,000	—	—	+12.2%	Open the original filing on SEC.gov
Jun 12, 2025	Valle William	Director	AGRANT◆	15,000	—	—	—	Open the original filing on SEC.gov
Jun 12, 2025	Wahlstrom Mats	Director	AGRANT◆	15,000	—	—	—	Open the original filing on SEC.gov
Jun 12, 2025	Murphy Sean	Director	AGRANT◆	15,000	—	—	—	Open the original filing on SEC.gov
Jun 12, 2025	Matlin David J	Director	AGRANT◆	15,000	—	—	—	Open the original filing on SEC.gov
Jun 12, 2025	Hicks Kerry R	Director	AGRANT◆	15,000	—	—	—	Open the original filing on SEC.gov
Jun 12, 2025	Gordon Gary B.	Director	AGRANT◆	15,000	—	—	—	Open the original filing on SEC.gov
Jun 12, 2025	Desai Arjun JJ	Director	AGRANT◆	15,000	—	—	—	Open the original filing on SEC.gov
May 19, 2025	Young James Emmett	Chief Financial Officer	AGRANT	13,175	$5.18	$68.2K	+36.1%	Open the original filing on SEC.gov
May 19, 2025	Stevens Jennifer	Chief Regulatory Officer	SSELL	8,704	$5.18	$45.1K	-10.1%	Open the original filing on SEC.gov
May 19, 2025	Stevens Jennifer	Chief Regulatory Officer	AGRANT	28,455	$5.18	$147.4K	+49.1%	Open the original filing on SEC.gov
May 19, 2025	Murphy Sean	Director	AGRANT	44,884	$5.18	$232.5K	+56.7%	Open the original filing on SEC.gov
May 19, 2025	Marshak Richard	Chief Commercial Officer	SSELL	6,597	$5.18	$34.2K	-8.7%	Open the original filing on SEC.gov
May 19, 2025	Marshak Richard	Chief Commercial Officer	AGRANT	21,428	$5.18	$111K	+39.5%	Open the original filing on SEC.gov
May 19, 2025	Devlin Jodi	Chief of Clinical…	SSELL	4,764	$5.18	$24.7K	-8.3%	Open the original filing on SEC.gov
May 19, 2025	Devlin Jodi	Chief of Clinical…	AGRANT	24,131	$5.18	$125K	+72.3%	Open the original filing on SEC.gov
May 19, 2025	Cox Bryan F.	Chief of Research	SSELL	4,764	$5.18	$24.7K	-3.8%	Open the original filing on SEC.gov
May 19, 2025	Cox Bryan F.	Chief of Research	AGRANT	15,722	$5.18	$81.4K	+14.5%	Open the original filing on SEC.gov
Feb 13, 2024	Szela Mary T	CEO and President	AGRANT	125,000	—	—	+64.8%	Open the original filing on SEC.gov

FTAX$65.3K

Patience David · Chief Financial…Jul 1

14,650 sh @ $4.46 · -5.3% own

AGRANT$15.4K

Szela Mary T · CEO and PresidentJun 30

3,990 sh @ $3.87 · +0.4% own

AGRANT$2.2K

Marshak Richard · Chief Commercial…Jun 30

561 sh @ $3.87 · +0.4% own

AGRANT◆—

Marshall Richard Henry · Chief Medical…Jun 29

120,000 sh

AGRANT—

Marshall Richard Henry · Chief Medical…Jun 29

60,000 sh · +200.0% own

PBUY★$151.8K

Wahlstrom Mats · DirectorMay 15

60,000 sh @ $2.53 · +68.5% own

PBUY↓$102.8K

Szela Mary T · CEO and PresidentMay 15

39,682 sh @ $2.59 · +3.9% own

PBUY$500K

Stansky Michael P · DirectorMay 15

200,000 sh @ $2.50 · +100.2% own

PBUY↓$1M

Stansky Michael P · DirectorMay 15

410,000 sh @ $2.50 · +49.4% own

PBUY↓$17.3K

Patience David · Chief Financial…May 15

7,100 sh @ $2.43 · +2.6% own

PBUY↓$24.6K

Gordon Gary B. · DirectorMay 15

10,000 sh @ $2.46 · +16.0% own

SSELL$1.4K

Marshak Richard · Chief Commercial…May 15

543 sh @ $2.67 · -0.4% own

AGRANT◆—

Wahlstrom Mats · DirectorMay 14

75,204 sh

AGRANT—

Wahlstrom Mats · DirectorMay 14

34,226 sh · +64.2% own

AGRANT—

Wahlstrom Mats · DirectorMay 14

37,602 sh · +239.1% own

AGRANT◆—

Valle William · DirectorMay 14

56,403 sh

AGRANT—

Valle William · DirectorMay 14

24,553 sh · +41.8% own

AGRANT—

Valle William · DirectorMay 14

28,201 sh · +92.5% own

AGRANT◆—

Stansky Michael P · DirectorMay 14

47,003 sh

AGRANT—

Stansky Michael P · DirectorMay 14

20,089 sh · +2.5% own

AGRANT—

Stansky Michael P · DirectorMay 14

23,501 sh · +3.0% own

AGRANT◆—

Matlin David J · DirectorMay 14

56,403 sh

AGRANT—

Matlin David J · DirectorMay 14

23,065 sh · +1.8% own

AGRANT—

Matlin David J · DirectorMay 14

28,201 sh · +2.2% own

AGRANT◆—

Hicks Kerry R · DirectorMay 14

56,403 sh

AGRANT—

Hicks Kerry R · DirectorMay 14

28,201 sh · +5.5% own

AGRANT◆—

Gordon Gary B. · DirectorMay 14

56,403 sh

AGRANT—

Gordon Gary B. · DirectorMay 14

24,553 sh · +64.7% own

AGRANT—

Gordon Gary B. · DirectorMay 14

28,201 sh · +289.1% own

SSELL$61.4K

Szela Mary T · CEO and PresidentMar 17

15,944 sh @ $3.85 · -2.1% own

SSELL$3.2K

Stevens Jennifer · Chief Regulatory…Mar 16

774 sh @ $4.12 · -0.6% own

SSELL$1.7K

Marshak Richard · Chief Commercial…Mar 16

419 sh @ $4.12 · -0.4% own

SSELL$1.1K

Devlin Jodi · Chief of Clinical…Mar 16

273 sh @ $4.12 · -0.3% own

SSELL$2.4K

Cox Bryan F. · Chief of ResearchMar 16

579 sh @ $4.12 · -0.4% own

SSELL$6.3K

Stevens Jennifer · Chief Regulatory…Mar 12

1,552 sh @ $4.09 · -1.2% own

SSELL$6.5K

Marshak Richard · Chief Commercial…Mar 12

1,589 sh @ $4.09 · -1.4% own

SSELL$7.2K

Devlin Jodi · Chief of Clinical…Mar 12

1,772 sh @ $4.09 · -1.8% own

SSELL$6K

Cox Bryan F. · Chief of ResearchMar 12

1,467 sh @ $4.09 · -0.9% own

SSELL$18K

Szela Mary T · CEO and PresidentMar 11

4,358 sh @ $4.13 · -0.6% own

SSELL$5K

Stevens Jennifer · Chief Regulatory…Mar 11

1,204 sh @ $4.13 · -0.9% own

SSELL$6K

Marshak Richard · Chief Commercial…Mar 11

1,449 sh @ $4.13 · -1.3% own

SSELL$4.8K

Devlin Jodi · Chief of Clinical…Mar 11

1,162 sh @ $4.13 · -1.2% own

SSELL$4.7K

Cox Bryan F. · Chief of ResearchMar 11

1,138 sh @ $4.13 · -0.7% own

PBUY★$125K

Valle William · DirectorFeb 23

30,487 sh @ $4.10

PBUY★$125K

Szela Mary T · CEO and PresidentFeb 23

30,487 sh @ $4.10 · +4.1% own

PBUY$480.5K

Stansky Michael P · DirectorFeb 23

117,198 sh @ $4.10 · +142.1% own

PBUY★$1M

Stansky Michael P · DirectorFeb 23

243,900 sh @ $4.10 · +44.9% own

PBUY★$15K

Patience David · Chief Financial…Feb 23

3,657 sh @ $4.10 · +1.4% own

PBUY★$40K

Gordon Gary B. · DirectorFeb 23

9,756 sh @ $4.10

AGRANT◆—

Stansky Michael P · DirectorFeb 4

92,537 sh

AGRANT◆—

Szela Mary T · CEO and PresidentNov 24, 2025

250,000 sh

AGRANT—

Szela Mary T · CEO and PresidentNov 24, 2025

300,000 sh · +67.8% own

AGRANT—

Szela Mary T · CEO and PresidentNov 24, 2025

125,000 sh · +39.3% own

AGRANT◆—

Stevens Jennifer · Chief Regulatory…Nov 24, 2025

100,000 sh

AGRANT—

Stevens Jennifer · Chief Regulatory…Nov 24, 2025

50,000 sh · +64.4% own

AGRANT◆—

Patience David · Chief Financial…Nov 24, 2025

130,000 sh

AGRANT—

Patience David · Chief Financial…Nov 24, 2025

65,000 sh · +32.5% own

AGRANT◆—

Marshak Richard · Chief Commercial…Nov 24, 2025

120,000 sh

AGRANT—

Marshak Richard · Chief Commercial…Nov 24, 2025

60,000 sh · +111.4% own

AGRANT◆—

Devlin Jodi · Chief of Clinical…Nov 24, 2025

100,000 sh

AGRANT—

Devlin Jodi · Chief of Clinical…Nov 24, 2025

50,000 sh · +98.9% own

AGRANT◆—

Cox Bryan F. · Chief of ResearchNov 24, 2025

80,000 sh

AGRANT—

Cox Bryan F. · Chief of ResearchNov 24, 2025

40,000 sh · +31.6% own

AGRANT◆—

Patience David · Chief Financial…Aug 28, 2025

248,899 sh

AGRANT◆—

Patience David · Chief Financial…Aug 14, 2025

290,000 sh

AGRANT—

Patience David · Chief Financial…Aug 14, 2025

200,000 sh

CCONV◆—

Matlin David J · DirectorJul 31, 2025

100,000 sh

CCONV—

Matlin David J · DirectorJul 31, 2025

330,000 sh · +35.0% own

CCONV◆—

Frankenius Equity AB · 10% OwnerJul 31, 2025

230,000 sh

CCONV—

Frankenius Equity AB · 10% OwnerJul 31, 2025

759,000 sh · +12.2% own

AGRANT◆—

Valle William · DirectorJun 12, 2025

15,000 sh

AGRANT◆—

Wahlstrom Mats · DirectorJun 12, 2025

15,000 sh

AGRANT◆—

Murphy Sean · DirectorJun 12, 2025

15,000 sh

AGRANT◆—

Matlin David J · DirectorJun 12, 2025

15,000 sh

AGRANT◆—

Hicks Kerry R · DirectorJun 12, 2025

15,000 sh

AGRANT◆—

Gordon Gary B. · DirectorJun 12, 2025

15,000 sh

AGRANT◆—

Desai Arjun JJ · DirectorJun 12, 2025

15,000 sh

AGRANT$68.2K

Young James Emmett · Chief Financial…May 19, 2025

13,175 sh @ $5.18 · +36.1% own

SSELL$45.1K

Stevens Jennifer · Chief Regulatory…May 19, 2025

8,704 sh @ $5.18 · -10.1% own

AGRANT$147.4K

Stevens Jennifer · Chief Regulatory…May 19, 2025

28,455 sh @ $5.18 · +49.1% own

AGRANT$232.5K

Murphy Sean · DirectorMay 19, 2025

44,884 sh @ $5.18 · +56.7% own

SSELL$34.2K

Marshak Richard · Chief Commercial…May 19, 2025

6,597 sh @ $5.18 · -8.7% own

AGRANT$111K

Marshak Richard · Chief Commercial…May 19, 2025

21,428 sh @ $5.18 · +39.5% own

SSELL$24.7K

Devlin Jodi · Chief of Clinical…May 19, 2025

4,764 sh @ $5.18 · -8.3% own

AGRANT$125K

Devlin Jodi · Chief of Clinical…May 19, 2025

24,131 sh @ $5.18 · +72.3% own

SSELL$24.7K

Cox Bryan F. · Chief of ResearchMay 19, 2025

4,764 sh @ $5.18 · -3.8% own

AGRANT$81.4K

Cox Bryan F. · Chief of ResearchMay 19, 2025

15,722 sh @ $5.18 · +14.5% own

AGRANT—

Szela Mary T · CEO and PresidentFeb 13, 2024

125,000 sh · +64.8% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

16 of 44 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 443 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Insider	Past deadline	Largest line	Source
Feb 13, 2024	Nov 24, 2025	Szela Mary TCEO and President	443days · about 1.8 years	—	Filing ↗
Jul 31, 2025	Apr 19	Frankenius Equity AB10% Owner	176days · about 8 months	—	Filing ↗
Jul 31, 2025	Mar 31	Matlin David JDirector	163days · about 8 months	—	Filing ↗
Jun 12, 2025	Jun 26, 2025	Matlin David JDirector	7days	—	Filing ↗
Jun 12, 2025	Jun 26, 2025	Hicks Kerry RDirector	7days	—	Filing ↗

Szela Mary TCEO and President

443days · about 1.8 years

Traded Feb 13, 2024 · filed Nov 24, 2025Filing ↗

Frankenius Equity AB10% Owner

176days · about 8 months

Traded Jul 31, 2025 · filed Apr 19Filing ↗

Matlin David JDirector

163days · about 8 months

Traded Jul 31, 2025 · filed Mar 31Filing ↗

Matlin David JDirector

7days

Traded Jun 12, 2025 · filed Jun 26, 2025Filing ↗

Hicks Kerry RDirector

7days

Traded Jun 12, 2025 · filed Jun 26, 2025Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More healthcare services companies

Other issuers in the same industry with insider filings on record.

Whole sector →